PROSPECTIVE STUDY IN PATIENTS WITH OSTEOPOROSIS: ADHERENCE AND PERSISTENCE WITH ANTIOSTEOPOROTIC DRUGS

被引：0
|
作者：
Toroptsova, N. [1 ]
Nikitinskaya, O. [1 ]
机构：
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4264
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0817
引用
收藏
页码：1073 / 1073
页数：1
相关论文
共 50 条
  • [1] BEST - THE BONE EVALUATION STUDY: PERSISTENCE ANALYSIS OF PATIENTS TREATED WITH ANTIOSTEOPOROTIC DRUGS
    Schmid, Tamara
    Linder, Roland
    Steinle, Thomas
    Eisen, Christoph
    Hadji, Peyman
    Rowinski-Jablokow, Maciej
    Klein, Silvia
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S118 - S119
  • [2] Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database
    Confavreux, Cyrille B.
    Canoui-Poitrine, Florence
    Schott, Anne-Marie
    Ambrosi, Veronique
    Tainturier, Valerie
    Chapurlat, Roland D.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (04) : 735 - 741
  • [3] PERSISTENCE AT 1 YEAR OF SEVERAL ORAL ANTIOSTEOPOROTIC DRUGS AS A FUNCTION OF DOSING FREQUENCY: A PROSPECTIVE STUDY
    Confavreux, C. B.
    Canoui-Poitrine, F.
    Tainturier, V.
    Schott, A.
    Chapurlat, R.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 83 - 84
  • [4] PERSISTENCE WITH ANTIOSTEOPOROTIC DRUGS: A RETROSPECTIVE POPULATION-BASED COHORT STUDY
    Iolascon, G.
    Capaldo, A.
    Orlando, V.
    Menditto, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1043 - 1044
  • [5] PERSISTENCE WITH ANTIOSTEOPOROTIC DRUGS: A RETROSPECTIVE POPULATION-BASED COHORT STUDY
    Iolascon, G.
    Capaldo, A.
    Orlando, V.
    Menditto, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 147 - 147
  • [6] The Lack of Adherence to Antiosteoporotic Drugs: Crossing Methods, the Key to Adherence Measurement?
    Saliba, Layla
    Boisson, Laura
    Sallerin, Brigitte
    Laroche, Michel
    Despas, Fabien
    THERAPIE, 2014, 69 (05): : 383 - 389
  • [7] Adherence and persistence in patients with severe osteoporosis treated with teriparatide
    Ziller, V.
    Zimmermann, S. P.
    Kalder, M.
    Ziller, M.
    Sekar-Pektas, B.
    Hellmeyer, L.
    Hadji, P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 675 - 681
  • [8] Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene
    Ziller, V.
    Wetzel, K.
    Kyvernitakis, I.
    Seker-Pektas, B.
    Hadji, P.
    CLIMACTERIC, 2011, 14 (02) : 228 - 235
  • [9] PERSISTENCE TO ANTIOSTEOPOROTIC DRUGS IN REAL CLINICAL PRACTICE IN RUSSIA
    Nikitinskaya, O. A.
    Demin, N. V.
    Feklistov, A.
    Abramkin, A.
    Toroptsova, N. V.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S109 - S109
  • [10] PERSISTENCE TO THERAPY AND THE ASSOCIATED RISK OF FRACTURES WITH ANTIOSTEOPOROTIC DRUGS
    Orlando, Valentina V.
    Guerriero, Francesca F.
    Monetti, Valeria Marina V.
    Punzo, Maria Claudia M.
    Gimigliano, Francesca F.
    Iolascon, Giovanni G.
    Menditto, Enrica E.
    VALUE IN HEALTH, 2015, 18 (07) : A654 - A655
12345